For Cold and Flu, Innate Immunity Is the Key
With the winter season rapidly approaching, influenza virus infection and related sequelae are significant concerns to public health. With the success of the yearly flu vaccine being unpredictable at best, agents that modify the host response to infection have become increasingly attractive. One such agent, a hybridized mushroom extract called active hexose correlated compound (AHCC), has been reported to increase survival, decrease the severity of infection, and shorten recovery time in an established experimental model of influenza virus infection (J Nutr. 2006;136; Nutr Rev. 2008;66; Nutr Res. 2009;29).









0 Comments